Pneumococcal meningitis post-cochlear implantation: potential routes of infection and pathophysiology

Benjamin P C Wei1, Robert K Shepherd, Roy M Robins-Browne

  • 1Department of Otolaryngology, Bionic Ear Institute, University of Melbourne, Melbourne, Victoria, Australia.

Abstract

Insights

Cochlear implant recipients face a higher risk of pneumococcal meningitis. Laboratory studies reveal infection routes and how cochlear implants lower the threshold for this serious condition.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Neurosurgery

Background:

  • Pneumococcal meningitis poses a significant risk to cochlear implant recipients.
  • Understanding infection pathways is crucial for preventing serious complications.

Purpose of the Study:

  • To review current knowledge on pneumococcal meningitis in cochlear implant users.
  • To investigate Streptococcus pneumoniae infection routes to the meninges.
  • To explore the pathophysiology of meningitis in implant recipients.

Main Methods:

  • Comprehensive literature search of Medline/PubMed (post-1960).
  • Keywords: cochlear implants, meningitis, pneumococcus, Streptococcus pneumoniae.
  • Narrative review of all relevant studies, including laboratory animal research.

Main Results:

  • Incidence of pneumococcal meningitis is higher in cochlear implant recipients compared to the general population.
  • Laboratory studies identified specific infection routes and demonstrated that cochlear implants can lower the threshold for meningitis.
  • Animal models are essential for understanding implant-related infection risks.

Conclusions:

  • Laboratory findings enhance the understanding of clinical data regarding meningitis risk after cochlear implantation.
  • Further research is needed to fully elucidate the mechanisms and prevention strategies.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...